Lithuania.
Faculty of Clinical Informatics, London, UK.
Clin Med (Lond). 2020 May;20(3):324-328. doi: 10.7861/clinmed.2019-0317.
The aim was to help physicians engage with NHS and other policymakers about the use, procurement and regulation of artificial intelligence, algorithms and clinical decision support systems (CDSS) in the NHS by identifying the professional benefits of and concerns about these systems.
We piloted a three-page survey instrument with closed and open-ended questions on SurveyMonkey, then circulated it to specialty societies via email. Both quantitative and qualitative methods were used to analyse responses.
The results include the current usage of CDSS; identified benefits; concerns about quality; concerns about regulation, professional practice, ethics and liability, as well as actions being taken by the specialty societies to address these; and aspects of CDSS quality that need to be tested.
While results confirm many expected benefits and concerns about CDSS, they raise new professional concerns and suggest further actions to explore with partners on behalf of the physician community.
通过确定医生对这些系统的专业益处和担忧，帮助医生就 NHS 以及其他政策制定者关于在 NHS 中使用、采购和监管人工智能、算法和临床决策支持系统（CDSS）进行沟通。
我们在 SurveyMonkey 上试用了一个带有封闭式和开放式问题的三页调查问卷，然后通过电子邮件将其分发给专业协会。我们使用定量和定性方法来分析回复。
结果包括 CDSS 的当前使用情况；确定的益处；对质量的担忧；对监管、专业实践、道德和责任的担忧，以及专业协会为解决这些问题而采取的行动；以及需要测试的 CDSS 质量方面。
虽然结果证实了 CDSS 的许多预期益处和担忧，但它们也引发了新的专业担忧，并建议代表医生社区与合作伙伴进一步采取行动进行探索。
